Final Program

SUNDAY • MAY 15 61
Facilitator:
P1270
P1271
M.P. Keane, MD, Dublin, Ireland
Nanosilica and Polyacrylate/Nanosilica: A Comparative Study
of Acute Toxicity/Y. Niu, X.-L. Zhu, B. Chang, Z.-H. Tong, W. Cao,
P.-H. Qiao, L.-Y. Zhang, J. Zhao, Y.-G. Song, Beijing, China,
p.A1585
Eosinophilic Pneumonia Caused by Daptomycin: Five Case
Reports and Review of the Literature/J. Hirai, T. Kinjo, M.
Hagihara, H. Hashioka, M. Nakamatsu, S. Haranaga, Y. Yamagishi,
H. Mikamo, J. Fujita, Okinawa, Japan, p.A1586
P1272 Clinical Analysis of Drug-Induced Lung Disease/M. Nemoto, S.
Noma, S. Yamawaki, F. Suzuki, R. Tsuzuki, A. Otsuki, K.
Nakashima, M. Misawa, M. Aoshima, Kamogawa City, Japan,
p.A1587
P1273
P1274
P1275
Facilitator:
P1276
P1277
P1278
P1279
P1280
A45
Monitoring for Amiodarone Pulmonary Toxicity Is of Limited
Utility in Real World Practice/A. Toscano, T. Siddiqui, K. Tahir, S.
DeLisle, Baltimore, MD, p.A1588
Radiation Bronchial Necrosis: Clinical and Bronchoscopy
Features/O. Shtraichman, O. Fruchter, D. Rosengarten, A.R.
Nader, M.R. Kramer, Petach Tikva, Israel, p.A1589
Breast Cancer Therapy Is Associated with Respiratory Muscle
Weakness/K. Dittus, N. Kokinda, D. Rubin, D.A. Kaminsky, B.T.
Suratt, Burlington, VT, p.A1590
E.M. Fireman, PhD, Tel Aviv, Israel
Baseline Characteristics and Demographics of Patients
Receiving Daptomycin and Incidence of Toxicity Associated
with Daptomycin Use/M.K. Ellis, A. Szabo, K. Joshi, Milwaukee,
WI, p.A1591
Infectious Complications in Patients Receiving Biologic
Therapy/C. Ochoa, P. Rajaram, S. Tanukonda, R.T. Sadikot,
Atlanta, GA, p.A1592
Case-Control Study of HLA Region in Brazilian Carriers of
Granulomatosis with Polyangiitis (Wegener’s)/M.S. Tavares,
C.S.V. Barbas, L.K. Dourado, T. Antunes, J. Pinaffi, Sao Paulo,
Brazil, p.A1593
An Analysis of Pulmonary Manifestations of IgG4-Related
Disease/H. Sadamatsu, K. Takahashi, H. Tashiro, N.
Sueoka-Aragane, Saga, Japan, p.A1594
Clinical Features of IgG4-Related Respiratory Disease/S.
Matsui, H. Yamamoto, S. Minamoto, T. Handa, Y. Waseda, M.
Mishima, K. Kubo, Toyama, Japan, p.A1595
THEMATIC POSTER SESSION
LUNG DISEASE ASSOCIATED WITH BIOLOGICAL
THERAPY AND IMMUNOTHERAPY: CASE REPORTS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1282
P1283
P1284
P1285
P1286
P1287
P1288
P1289
P1290
P1291
P1292
A46
J.A. De Andrade, MD, Birmingham, AL
Acute Fibrinous Organizing Pneumonia: Rituximab Induced
Fibrin Balls Within Alveoli, an Unknown Entity/N. Victor, Dover,
DE, p.A1596
Cryptogenic Organizing Pneumonia in a Patient with Crohn’s
Disease on Infliximab- An Extra Intestinal Pulmonary
Manifestation or Drug Induced Complication?/M. Mauro, N.
Yellappa, I. Harbuz-Miller, D. Markley, Morristown, NJ, p.A1597
Clinical Conundrum: A Case of Afatinib-Induced Interstitial
Lung Disease/S.E. Wu, M.H. Lee, A. Mednick, New York, NY,
p.A1598
Drug Induced Organizing Pneumonia by Immune-Checkpoint
Inhibitor, Nivolumab/M. Nagamata, M. Yomota, T. Okamura, K.
Yoshino, T. Hishima, Tokyo, Japan, p.A1599
Tarceva Induced Fatal Interstitial Lung Disease: An
Underreported Toxicity/R. Sedhom, E. Gorshein, S. Wong, New
Brunswick, NJ, p.A1600
Severe Symptomatic Hypercalcemia and Diffuse Pulmonary
Nodules as the Presenting Symptoms of Adalimumab Induced
Sarcoid-Like Granulomatosis/C. Bielick, W. Wong, A. Sosa,
Worcester, MA, p.A1601
Golimumab Induced Sarcoid-Like Interstitial Lung Disease and
Pulmonary Hypertension/W. He, B. Mann, M.B. Beasley, H. Poor,
New York City, NY, p.A1602
Pneumonitis Secondary to Combination CTLA-4 and PD-L1
Inhibitor Therapy: A Case Report/A.D. Zider, O. Fried, K.
Ruchalski, A. Gutierrez, D. Wong, J.W. Goldman, Los Angeles, CA,
p.A1603
Rituximab-Induced Hypersensitivity Pneumonitis Masked by
Concomitant Corticosteroid Therapy/M.Q. Khan, S. Bellam,
Evanston, IL, p.A1604
Immunotherapy in Metastatic Melanoma: A Case of Pulmonary
Non-Caseating Granulomas/S. Srinivas, C. Reichner,
Washington, DC, p.A1605
Did Rituximab Do the Trick?/A. Gupta, R. Gripaldo, Columbia,
SC, p.A1606
THEMATIC POSTER SESSION
LUNG DISEASE DUE TO OTC AND ILLICITS: CASE
REPORTS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1294
N. Patel, MD, Philadelphia, PA
Jagged Little Pills: A Case of Pulmonary Deposition of
Intravenously Injected Crushed Oral Tablets/M. Werlang, B.
Hiroto, I. Mira-Avendano, Jacksonville, FL, p.A1607
SUNDAY MORNING
ATS 2016 • San Francisco